CYTK
Price
$33.57
Change
+$0.09 (+0.27%)
Updated
Dec 1, 6:59 PM EST
81 days until earnings call
INMB
Price
$9.61
Change
+$0.16 (+1.69%)
Updated
Dec 1, 6:59 PM EST
88 days until earnings call
Ad is loading...

Compare trend and price CYTK vs INMB

Header iconCYTK vs INMB Comparison
Open Charts CYTK vs INMBBanner chart's image
Cytokinetics
Price$33.57
Change+$0.09 (+0.27%)
Volume$971.19K
CapitalizationN/A
INmune Bio
Price$9.61
Change+$0.16 (+1.69%)
Volume$29.46K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs INMB Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CYTK vs. INMB commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and INMB is a Buy.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (CYTK: $33.57 vs. INMB: $9.61)
Brand notoriety: CYTK and INMB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 106% vs. INMB: 156%
Market capitalization -- CYTK: $3.12B vs. INMB: $168.86M
CYTK [@Biotechnology] is valued at $3.12B. INMB’s [@Biotechnology] market capitalization is $168.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 6 TA indicator(s) are bullish while INMB’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 6 bullish, 2 bearish.
  • INMB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than INMB.

Price Growth

CYTK (@Biotechnology) experienced а +5.00% price change this week, while INMB (@Biotechnology) price change was +3.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 22, 2024.

INMB is expected to report earnings on Feb 29, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for INMB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($3.12B) has a higher market cap than INMB($169M). INMB YTD gains are higher at: 51.577 vs. CYTK (-26.735). INMB has higher annual earnings (EBITDA): -27M vs. CYTK (-462.64M). CYTK has more cash in the bank: 539M vs. INMB (41.8M). INMB has less debt than CYTK: INMB (12.9M) vs CYTK (748M). CYTK has higher revenues than INMB: CYTK (7.82M) vs INMB (224K).
CYTKINMBCYTK / INMB
Capitalization3.12B169M1,847%
EBITDA-462.64M-27M1,713%
Gain YTD-26.73551.577-52%
P/E RatioN/AN/A-
Revenue7.82M224K3,489%
Total Cash539M41.8M1,289%
Total Debt748M12.9M5,798%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKINMB
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLIQX18.690.41
+2.24%
Clifford Capital Partners Super Instl
SSCCX0.920.02
+2.22%
Saratoga Small Capitalization C
LVOQX15.510.31
+2.04%
Lord Abbett Value Opportunities R2
PWJZX27.520.20
+0.73%
PGIM Jennison International Opps Z
HSGFX6.300.01
+0.16%
Hussman Strategic Growth

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+1.69%
MDGL - INMB
41%
Loosely correlated
+4.83%
ORMP - INMB
38%
Loosely correlated
-4.05%
AXON - INMB
37%
Loosely correlated
+0.71%
EIGR - INMB
34%
Loosely correlated
-0.03%
CYTK - INMB
34%
Loosely correlated
+0.27%
More